Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with imatinib

被引：43

作者：

Meeus, P

Demuynck, H

Martiat, P

Michaux, L

Wouters, E

Hagemeijer, A

机构：

[1] Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium

[2] Onze Lieve Vrouwe Ziekenhuis, Aalst, Belgium

[3] Heilig Hart Ziekenhuis, Roeselare, Belgium

[4] ULB, Inst Jules Bordet, Serv Hematol, Brussels, Belgium

[5] UCL St Luc, Serv Hematol, Brussels, Belgium

来源：

LEUKEMIA | 2003年 / 17卷 / 02期

关键词：

D O I：

10.1038/sj.leu.2402791

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：465 / 467

页数：3

共 7 条

[1] Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8 [J].

Andersen, MK ;

Pedersen-Bjorgaard, J ;

Kjeldsen, L ;

Dufva, IH ;

Brondum-Nielsen, K .

LEUKEMIA, 2002, 16 (07) :1390-1393

[2] Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience [J].

Braziel, RM ;

Launder, TM ;

Druker, BJ ;

Olson, SB ;

Magenis, RE ;

Mauro, MJ ;

Sawyers, CL ;

Paquette, RL ;

O'Dwyer, ME .

BLOOD, 2002, 100 (02) :435-441

[3] Spotlight imatinib: a model for signal transduction inhibitors [J].

Hochhaus, A ;

McCubrey, JA ;

Killmann, NMB .

LEUKEMIA, 2002, 16 (07) :1205-1206

[4] Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. [J].

Kantarjian, H ;

Sawyers, C ;

Hochhaus, A ;

Guilhot, F ;

Schiffer, C ;

Gambacorti-Passerini, C ;

Niederwieser, D ;

Resta, D ;

Capdeville, R ;

Zoellner, U ;

Talpaz, M ;

Druker, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09) :645-652

[5]

MARKTEL S, 2002, J HEMATOL S1, V3, P175

[6] Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study [J].

Sawyers, CL ;

Hochhaus, A ;

Feldman, E ;

Goldman, JM ;

Miller, CB ;

Ottmann, OG ;

Schiffer, CA ;

Talpaz, M ;

Guilhot, F ;

Deininger, MWN ;

Fischer, T ;

O'Brien, SG ;

Stone, RM ;

Gambacorti-Passerini, CB ;

Russell, NH ;

Reiffers, JJ ;

Shea, TC ;

Chapuis, B ;

Coutre, S ;

Tura, S ;

Morra, E ;

Larson, RA ;

Saven, A ;

Peschel, C ;

Gratwohl, A ;

Mandelli, F ;

Ben-Am, M ;

Gathmann, I ;

Capdeville, R ;

Paquette, RL ;

Druker, BJ .

BLOOD, 2002, 99 (10) :3530-3539

[7] Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study [J].

Talpaz, M ;

Silver, RT ;

Druker, BJ ;

Goldman, JM ;

Gambacorti-Passerini, C ;

Guilhot, F ;

Schiffer, CA ;

Fischer, T ;

Deininger, MWN ;

Lennard, AL ;

Hochhaus, A ;

Ottmann, OG ;

Gratwohl, A ;

Baccarani, M ;

Stone, R ;

Tura, S ;

Mahon, FX ;

Fernandes-Reese, S ;

Gathmann, I ;

Capdeville, R ;

Kantarjian, HM ;

Sawyers, CL .

BLOOD, 2002, 99 (06) :1928-1937

← 1 →